Can a robotic glove restore hand function after stroke or injury?

NCT ID NCT07739264

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This pilot trial asks whether adding a robotic hand-training device to standard rehabilitation is safe, practical, and helpful for people with arm and hand motor problems caused by stroke, incomplete spinal cord injury, traumatic brain injury, or orthopedic conditions. Participants are randomly assigned to receive either standard rehab alone or standard rehab plus three weekly sessions of robotic hand training for 12 weeks. Researchers will compare changes in muscle strength, grip, range of motion, and daily function, while also monitoring for any device-related side effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
ZEPU-SG1PLUS Hand Functional Comprehensive Training System, a non-powered robotic device for hand and upper limb training
What this could lead to
If effective, this robotic training device could become a practical addition to rehabilitation programs, helping people regain more arm and hand function after stroke, spinal cord injury, or brain injury.
What could go wrong
This is a small pilot study, so results may not apply broadly. The device could cause side effects like skin irritation or joint pain, and it may not prove more helpful than standard rehab alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INCOMPLETE SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bangladesh Medical University

    Dhaka, 1000, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.